Home/Filings/4/0001104659-21-069879
4//SEC Filing

Einhorn Andrew J. 4

Accession 0001104659-21-069879

CIK 0001739426other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:06 PM ET

Size

5.7 KB

Accession

0001104659-21-069879

Insider Transaction Report

Form 4
Period: 2021-05-18
Einhorn Andrew J.
Chief Financial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2021-05-18$3.12/sh6,467$20,177151,080 total
Holdings
  • Ordinary Shares

    (indirect: By family limited liability company)
    22,852
Footnotes (1)
  • [F1]The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Issuer

Osmotica Pharmaceuticals plc

CIK 0001739426

Entity typeother

Related Parties

1
  • filerCIK 0001560685

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:06 PM ET
Size
5.7 KB